Insider Transactions in Q1 2021 at Medifast Inc (MED)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2021
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,495
+3.74%
|
-
|
|
Mar 17
2021
|
James P. Maloney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
776
+28.28%
|
-
|
|
Mar 17
2021
|
Stephen Kyle Johnson VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
272
+29.03%
|
-
|
|
Mar 03
2021
|
Constance J. Hallquist |
SELL
Open market or private sale
|
Direct |
4,500
-41.65%
|
$1,165,500
$259.02 P/Share
|
|
Mar 03
2021
|
Constance J. Hallquist |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+18.87%
|
$126,000
$28.14 P/Share
|
|
Feb 20
2021
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.0%
|
$268
$268.23 P/Share
|
|
Feb 19
2021
|
Stephen Kyle Johnson VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
43
-9.86%
|
$11,524
$268.23 P/Share
|
|
Feb 19
2021
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.0%
|
$268
$268.23 P/Share
|
|
Feb 05
2021
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
132
+0.46%
|
$31,680
$240.99 P/Share
|
|
Jan 14
2021
|
Kevin G Byrnes Director |
SELL
Bona fide gift
|
Direct |
2,000
-19.65%
|
-
|